Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

Edmond J Lewis, Lawrence G Hunsicker, William R Clarke, Tomas Berl, Marc A Pohl, Julia B Lewis, Eberhard Ritz, Robert Charles Atkins, Richard Rohde, Itamar Raz

Research output: Contribution to journalArticleResearchpeer-review

4586 Citations (Scopus)
Original languageEnglish
Pages (from-to)851 - 860
Number of pages10
JournalThe New England Journal of Medicine
Volume345
Issue number12
Publication statusPublished - 2001

Cite this

Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001). Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. The New England Journal of Medicine, 345(12), 851 - 860.